2024 Japan Nucleic Acid Testing/NAT Market for 100 Assays: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

2024 Japan Nucleic Acid Testing/NAT Market for 100 Assays: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

  • July 2020 •
  • 1126 pages •
  • Report ID: 5877947 •
  • Format: PDF
2024 Japan Nucleic Acid Testing/NAT Market for 100 Assays: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

This new 1,126-page report contains 56 table.

The report is available by section, and can be customized to specific information needs and budget.The report presents a comprehensive analysis of the Japanese molecular diagnostics market, including:

  • Major issues pertaining to the Japanese molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
  • An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.
  • Five-year test volume and reagent sales forecasts for the following categories:

    - Infectious Diseases        - Forensic Testing
    -Cancer                                - Paternity Testing/HLA Typing
    - Genetic Diseases             - Others

    • Review of testing methodologies an instrumentation technologies.
    • Feature comparison of automated and semiautomated analyzers.
    • Sales and market shares of leading suppliers.
    • Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products.
    • Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in RandD, collaborative arrangements and business strategies.
    • Alternative market penetration strategies.
    • Potential market entry barriers and risks.
    • Business planning issues and concerns.
    Contains 1,126 pages and 56 tables
    Companies Profiled

    Competitive Assessments

    - Abbott
    - Affymetrix
    - Agilent Technologies
    - Applied Gene Technologies
    - Arca Biopharma
    - Beckman Coulter/Danaher
    - Becton Dickinson
    - Biokit
    - bioMerieux
    - Bio-Rad
    - Biotest
    - Cepheid
    - Decode Genetics
    - Diadexus
    - Eiken Chemical
    - Elitech Group
    - Enzo Biochem
    - Exact Sciences
    - Fujirebio
    - Grifols
    - Hologic
    - Illumina
    - LabCorp
    - Leica Biosystems
    - Li-Cor Biosciences
    - Myriad Genetics
    - Ortho-Clinical Diagnostics
    - PerkinElmer
    - Proteome Sciences
    - Qiagen
    - Roche
    - Scienion
    - Sequenom
    - Shimadzu
    - Siemens Healthineers
    - Sierra Molecular
    - Takara Bio
    - Tecan Group
    - Thermo Fisher